Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum β-lactamase-producing evaluation

Diagnostic Microbiology and Infectious Disease

Volumn 56, Issue 4, 2006, Pages 415-420

  Mendonça, Nuno ^a   Ferreira, Eugénia ^a   Caniça, Manuela ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

ESBL detection; Extended spectrum lactamases; Klebsiella pneumoniae; Portugal; SHV 28; SHV 5; SHV 55

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; AZTREONAM PLUS CLAVULANATE; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFTRIAXONE PLUS CLAVULANATE; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MECILLINAM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL PROTOCOL; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DILUTION; ENZYME ASSAY; ENZYME SYNTHESIS; EVALUATION; GOLD STANDARD; KLEBSIELLA PNEUMONIAE; LABORATORY DIAGNOSIS; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PORTUGAL; PRIORITY JOURNAL; REFERENCE VALUE;

BASE SEQUENCE; BETA-LACTAMASES; CEPHALOSPORINS; CLAVULANIC ACID; GENES, BACTERIAL; GUIDELINES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PORTUGAL; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY;

EID: 33845191164     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.06.023     Document Type: Article

References (25)

1. Belaaouaj A., Lapoumeroulie C., Caniça M.M., Vedel G., Névot P., Krishnamoorthy R., and Paul G. Nucleotide sequences of the genes coding for TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS. Microbiol. Lett. 120 (1994) 75-80
2. Bradford P. Extended-spectrum-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
3. TEM genes encoding β-lactamases resistant to clavulanic acid in clinical Escherichia coli. J. Mol. Evol. 44 (1997) 57-65
4. Caniça M.M., Barthelemy M., Gilly L., Labia R., Krishnamoorthy R., and Paul G. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob. Agents Chemother. 41 (1997) 374-378
5. Cavallo J.D., Chardon H., Chidiac C., Choutet P., Courvalin P., Dabernat H., Drugeon H., Dubreuil L., Goldstein F., Jarlier V., Leclercq R., Nicolas-Chanoine M.H., Philippon A., Quentin C., Rouveix B., Sirot J., and Soussy C.-J. Communiqué 2005. Comité de l'antibiogramme de la Société Française de Microbiologie, Paris, France (2005)
6. Edelstein M., Pimkin M., Edelstein I., and Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47 (2003) 3724-3732
7. Féria C., Ferreira E., Correia J.D., Gonçalves J., and Caniça M. Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J. Antimicrob. Chemother. 49 (2002) 77-85
8. Florijn A., Nijssen S., Schmitz F.-J., Verhoef J., and Fluit A.C. Comparison of E-Test and double disk diffusion test for detection of extended spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 21 (2002) 241-243
9. Gutmann L., Ferré B., Goldstein F.W., Risk N., Pinto-Schuster E., Acar J.F., and Collatz E. SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob. Agents Chemother. 33 (1989) 951-956
10. Inouye S., Soberon X., Franceschini T., Nakamura K., Itakura K., and Intuye M. Role of positive charge on the amino-terminal region of the signal peptide in protein secretion across the membrane. Proc. Natl. Acad. Sci. U. S. A. 79 (1982) 3438-3441
11. Jacoby G.A., and Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 34 (1996) 908-911
12. Komatsu M., Aihara M., Shimakawa K., Iwasaki M., Nagasaka Y., Fukuda S., Matsuo S., and Iwatani Y. Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum β-lactamases isolated in Japan. Diagn. Microbiol. Infect. Dis. 46 (2003) 125-130
13. Leverstein-van Hall M.A., Fluit A.C., Paauw A., Box A.T.A., Brisse S., and Verhoef J. Evaluation of the Etest ESBL and BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum β-lactamases in multiresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 40 (2002) 3703-3711
14. Linscott A.J., and Brown W.J. Evaluation of four commercially available extended-spectrum β-lactamase phenotypic confirmation tests. J. Clin. Microbiol. 43 (2005) 1081-1085
15. MacKenzie F.M., Miller C.A., and Gould I.M. Comparison of screening methods for TEM- and SHV-derived extended-spectrum β-lactamase detection. Clin. Microbiol. Infect. 8 (2002) 715-724
16. Moland E.S., Sanders C.C., and Thomson K.S. Can results obtained with commercially available microscan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?. J. Clin. Microbiol. 36 (1998) 2575-2579
17. Mulgrave L., and Attwood P.V. Characterization of an SHV-5 related extended broad-spectrum β-lactamase in Enterobacteriaceae from Western Australia. Pathology 25 (1993) 71-75
18. National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing; Fourteenth Informational Supplement M100-S14 (2004), National Committee for Clinical Laboratory Standards, Wayne, PA
19. Paterson D.L., and Bonomo R.A. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18 (2005) 657-686
20. Podbielski A., Schonling J., Melzer B., Warnatz K., and Leusch H.G. Molecular characterization of new plasmid-encoded SHV-type β-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J. Gen. Microbiol. 137 (1991) 569-578
21. Rice L.B., Carias L.L., Hujer A.M., Bonafede M., Hutton R., Hoyen C., and Bonomo R.A. High-level expression of chromosomally encoded SHV-1 β-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44 (2000) 362-367
22. Sabaté M., Miró E., Navarro F., Vergés C., Aliaga R., Mirelis B., and Prats G. β-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. Clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J. Antimicrob. Chemother. 49 (2002) 989-997
23. Schwaber M.J., Raney P.M., Rasheed K., Biddle J.W., Williams P., McGowan Jr. J.E., and Tenover F.C. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol. 42 (2004) 294-298
24. Tzouvelekis L.S., Vatopoulos A.C., Katsanis G., and Tzelepi E. Rare case of failure by an automated system to detect extended-spectrum β-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate. J. Clin. Microbiol. 37 (1999) 2388
25. Wu T.L., Siu L.K., Su L.H., Lauderdale T.L., Lin F.M., Leu H.S., Lin T.Y., and Ho M. Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 47 (2001) 755-761